0 CHECKOUT

Organophosphate And Carbamate Poisoning - Pipeline Review, H1 2015

  • ID: 3165009
  • March 2015
  • 32 pages
  • Global Markets Direct
1 of 4

Organophosphate And Carbamate Poisoning - Pipeline Review, H1 2015

Summary

This, ‘Organophosphate And Carbamate Poisoning - Pipeline Review, H1 2015’, provides an overview of the Organophosphate And Carbamate Poisoning’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Organophosphate And Carbamate Poisoning, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Organophosphate And Carbamate Poisoning and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put READ MORE >

Note: Product cover images may vary from those shown
2 of 4

List of Tables
List of Figures
Introduction
REPORT COVERAGE
Organophosphate And Carbamate Poisoning Overview
Therapeutics Development
Pipeline Products for Organophosphate And Carbamate Poisoning - Overview
Pipeline Products for Organophosphate And Carbamate Poisoning - Comparative Analysis
Organophosphate And Carbamate Poisoning - Therapeutics under Development by Companies
Organophosphate And Carbamate Poisoning - Therapeutics under Investigation by Universities/Institutes
Organophosphate And Carbamate Poisoning - Pipeline Products Glance
Early Stage Products
Organophosphate And Carbamate Poisoning - Products under Development by Companies
Organophosphate And Carbamate Poisoning - Products under Investigation by Universities/Institutes
Organophosphate And Carbamate Poisoning - Companies Involved in Therapeutics Development
Countervail Corporation
Organophosphate And Carbamate Poisoning - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
AM-132 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
galantamine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Organophosphate Poisoning - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit PARP-1 and Activate AChE for Organophosphates Poisoning - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Activate Acetylcholinesterase for Organophosphate Poisoning - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Organophosphate And Carbamate Poisoning - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Organophosphate And Carbamate Poisoning, H1 2015
Number of Products under Development for Organophosphate And Carbamate Poisoning - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Investigation by Universities/Institutes, H1 2015
Organophosphate And Carbamate Poisoning - Pipeline by Countervail Corporation, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Organophosphate And Carbamate Poisoning - Discontinued Products, H1 2015

List of Figures
Number of Products under Development for Organophosphate And Carbamate Poisoning, H1 2015
Number of Products under Development for Organophosphate And Carbamate Poisoning - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

Countervail Corporation

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Dow Chemical Co Ltd.
  • Huntsman Corporation
  • Evonik Industries AG
  • Cytec Industries Incorporated
  • Invista
  • Akzo Nobel N.V.